Vasopressin V1a receptors (V1aR) are thought to contribute to the pathophysiology of psychiatric disorders such as anxiety and depression, sparking interest in V1aR as a therapeutic target. Although the global effects of V1aR have been documented, less is known about the specific neural circuits mediating these effects. Moreover, few studies have examined context-specific V1aR function in both males and females. By using the California mouse, we first studied the effects of sex and social defeat stress on V1aR binding in the forebrain. In females but not males, V1aR binding in the bed nucleus of the stria terminalis (BNST) was negatively correlated to social interaction behavior. In females stress also increasesd V1aR binding in the nucleus accumbens (NAc). Infusions of V1aR antagonist in to the medioventral BNST (BNSTmv) had anxiogenic effects only in animals naïve to defeat. For males, inhibition of V1aR in BNSTmv had anxiogenic effects in social and nonsocial contexts, but for females, anxiogenic effects were limited to social contexts. In stressed females, inhibition of V1aR in the NAc shell had no effect on social interaction behavior, but had an anxiogenic effect in an open field test. These data suggest that V1aR in BNSTmv have anxiolytic and prosocial effects in males, and that in females, prosocial and anxiolytic effects of V1aR appear to be mediated independently by receptors in the BNSTmv and NAc shell, respectively. These findings suggest that males have more overlap in neural circuits modulating anxiety in social and nonsocial contexts than females.
Inhibition of vasopressin V1a receptors in the medioventral bed nucleus of the stria terminalis has sex-and context-specific anxiogenic effects 
Introduction
Vasopressin V1a receptors (V1aR) are key mediators of a myriad of social behaviors including social recognition (Bielsky et al., 2004) , social communication (Albers et al., 1986; Lukas and Wohr, 2015) , and social approach (Ramos et al., 2013) . Acute pharmacological inhibition of V1aRs can produce anxiolytic effects while genetic deletion of V1aR produced both anxiolytic effects and reductions in social function in male mice (Bielsky et al., 2004) . The modulation of both social behavior and anxiety by V1aR has sparked interest in its potential as a novel therapeutic target for stress-related psychiatric disorders, in which anxiety and social deficits can be comorbid (Lee et al., 2013; Meyer-Lindenberg and Tost, 2012) . Currently it is unclear whether the effects of V1aR on social and anxiety-like behaviors are mediated by independent or overlapping circuits. Although there are important species differences in V1aR binding (Bester-Meredith et al., 1999; Hammock and Young, 2006) , dense V1aR binding in the bed nucleus of the stria terminalis (BNST) is observed in a diverse group of rodents (Bales et al., 2007; Bosch et al., 2010) and primates (Freeman et al., 2014a (Freeman et al., , 2014b Young et al., 1999) . The BNST has been proposed to be a key nucleus for stress-induced psychiatric disorders (Lebow and Chen, 2016) , as it is an important regulator of both social behavior (O'Connell and Hofmann, 2011) and affective states (Avery et al., 2015; Hammack et al., 2012) . Thus, the BNST is well positioned to modulate effects of neuropeptides on anxiety and social behavior (Coria-Avila et al., 2014; Greenberg et al., 2014; Markham et al., 2009 ). The BNST is sexually dimorphic both at functional and anatomical levels , which is important because stress-induced psychiatric disorders are more common in women than men (Kessler et al., 1995) . Here we examined the effects of social stress on V1aR binding in the BNST and the effects of V1aR inactivation on behavior using the California mouse model of social defeat.
The California mouse is a monogamous species in which both males and females aggressively defend a joint territory (Ribble and Salvioni, 1990) . This social organization provides ethological validity to the use of protocols in which males and females experience social defeat . Three episodes of social defeat reduce social interaction behavior in females but not males (Greenberg et al., 2015; Trainor et al., 2011) . This effect is independent of gonadal steroids and can be reversed with chronic but not acute sertraline treatment . Male California mice exposed to defeat exhibit increased fear behavior in a resident-intruder test , similar to the conditioned defeat phenotype described in Syrian hamsters (Clinard et al., 2015; Gray et al., 2015) .
We first examined the effects of social defeat on V1aR binding in the hypothalamus, lateral septum, BNST, and nucleus accumbens (NAc). These nuclei are important regulators of social and affective behavior Walker and Davis, 2008) , and have strong connections with one another (O'Connell and Hofmann, 2011) . These data showed that in females but not males, V1aR expression is significantly increased in NAc core and shell, and that in the medioventral BNST (BNSTmv) social interaction behavior is negatively correlated with V1aR expression. In a previous study we observed that defeat increases the activity of OT neurons in the BNSTmv of females but not males and that intranasal OT reduces social interaction behavior in females but not males (Steinman et al., 2016) . Based on observations that V1aR can be activated by OT release (Song et al., 2014) , we hypothesized that stress-induced increases in the activity of OT neurons in the BNSTmv reduce social interaction behavior through activation of V1aR. To test this hypothesis, we examined the effects of V1aR antagonist in either the NAc or BNSTmv on social interaction behavior in females. In addition we examined the effects of V1aR inhibition in BNSTmv in the resident intruder test in males, based on previous work showing V1aR regulation of aggression. Our results provide important insights into how V1aR modulates anxiety-like behavior in social and nonsocial contexts in males and females.
Materials and methods

Experiments
Four experiments were conducted. Experiment 1: Effects of social defeat stress on V1aR binding in males (naïve n ¼ 8, stress ¼ 7) and females (naïve n ¼ 11, stress ¼ 9); Experiment 2: effects of V1aR antagonist infusion into BNSTmv on social interaction behavior in naïve (artificial cerebrospinal fluid (aCSF) n ¼ 6, V1aR antagonist n ¼ 10) and stressed (aCSF n ¼ 8, V1aR antagonist n ¼ 8) females; Experiment 3: effects of V1aR antagonist infusion into BNSTmv on social interaction behavior and territorial aggression in naïve (aCSF n ¼ 8, V1aR antagonist n ¼ 10) and stressed (aCSF n ¼ 8, V1aR antagonist n ¼ 9) males; and Experiment 4: effects of V1aR antagonist infusion into NAc shell on social interaction behavior in stressed females (aCSF n ¼ 7, V1aR antagonist n ¼ 8). Procedures are detailed below (see Fig. 1 for timelines).
Animals and housing conditions
Three-month old male and female California mice from our breeding colony at UC Davis were group housed (2e3 same-sex animals per cage). Those that underwent the cannula implantation surgery were singly housed immediately following the procedure. Animals were ear punched for identification and maintained in clear polypropylene cages in a room with controlled temperature (68e74 F) and 16L:8D light:dark cycle (lights off at 1400). Humidity was maintained at ambient levels. Water and food (Harlan Teklad 2016; Madison, WI) were provided ad libitum. Each polycarbonate plastic cage was provided with Sanichip bedding and environmental enrichment consisting of nestlets and envirodri. All procedures were approved by the Institutional Animal Care and Use Committee (IACUC) and conformed to NIH guidelines. All behavioral tests were conducted during lights out (1430e1730) under dim red light (3 lux).
Social defeat
Mice were randomly assigned to social defeat or control handling for 3 consecutive days. Mice assigned to social defeat were placed in the cage of an aggressive same-sex mouse . Each episode lasted 7 min or until the resident attacked the focal mouse 7 times (whichever occurred first). Control mice were introduced into a clean cage for 7 min. Immediately after defeat/ control, mice were returned to their home cage. All behavioral and receptor binding analyses were conducted two weeks after social defeat based on previous observations that the effects of defeat become stronger over time (Trainor et al., 2011) .
Social interaction test (SI)
Two weeks after defeat or control conditions, all animals were tested in SI as previously described Trainor et al., 2013) . First, each focal mouse was introduced into the open field (89 Â 63 Â 60 cm) for 3 min (open field phase). Total distance traveled (Anymaze, Stoelting) was recorded to assess locomotor behavior, and time spent in the center of the arena (within 8 cm of the sides and within a center zone located 14 cm from the sides) was recorded to assess anxiety-like behavior. Next, an empty wire cage was placed against one wall (acclimation phase). The amount of time that the focal mouse spent within 8 cm of the cage (interaction zone) and in the corners opposite to the wire cage was recorded for 3 min. Finally, an unfamiliar intact same-sex mouse was placed into the wire cage for 3 min (interaction phase) and the time spent in the interaction zone and corners was recorded (Fig. 2 ). Mice were returned to their home cage immediately after the end of SI. . Males and females were tested in social interaction test (SI) after one injection of V1aR antagonist or artificial cerebrospinal fluid (aCSF) into BNSTmv (exp. 2,3). Only males received a second injection before resident intruder test (RI) one day after SI (exp. 3). In experiment 4, only females were tested in SI after an injection of V1aR antagonist or into NAc shell. Arrows on top represent end of study for females (orange) and males (blue). (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
Receptor autoradiography
V1aR binding was measured using receptor autoradiography according to previously established methods (Perkeybile et al., 2015) . Immediately following SI testing mice were euthanized and brains were frozen on dry ice. Brains were sliced at 20 mm using a cryostat and mounted on Super-frost plus slides. Slides were fixed in 0.1% paraformaldehyde (Sigma Aldrich, St. Louis Missouri, USA) in phosphate buffered saline (PBS) for 2 min and then rinsed in two 10 min tris buffer washes 50 mM Trizma Base (Sigma, pH 7.4) followed by a 1 hr-room temperature incubation in 50 pM of radiotracer diluted in a tracer buffer (50 mM Trizma Base (pH 7.4), 10 mM MgCl2, 0.1% bovine serum albumin). We used 125 I-lin-vasopressin I-receptor binding. Uncalibrated optical density was converted disintegrations per minute (DPM) using the 125 I standards. If available, six sections per area were quantified bilaterally and then averaged for analysis. In some animals, one or two sections were damaged, so only four or five were available for analysis. The damaged sections were distributed across all four groups. On each section we also measured a nearby white matter tract that did not show receptor binding and subtracted this from the measurements for the area of interest to account for background (Inoue et al., 2013; Laredo et al., 2015) . There was no difference in signal in these regions and sections used to control for non-specific binding.
Cannula implantation surgery
Males and females were randomly assigned to control or defeat conditions as described above. Seven days after defeat or control handling, all mice were anesthetized with isoflurane (3e5%) and implanted with bilateral stainless steel guide cannula (Plastics One, C235G-2.2 W 1 mm PROJ) aimed at the BNSTmv (AP ¼ 0.39 mm, LM ¼ 1.1 mm, DV ¼ 6.85, Fig. 3 ). The guide cannulae (26 ga, o.d. ¼ 0.46 mm; i.d. ¼ 0.24 mm; length ¼ 5.85 mm), were lowered into burr holes (#105 dremel bit, 1/16 00 tip) and attached to the skull with skull screws (plastics one, 00-96 X 1/16) and acrylic dental cement. Bilateral dummy caps (Plastics One, C235DC) were used to maintain patency. Carprofen (5 mg/kg) was administered subcutaneously immediately before surgery and once a day during 3 consecutive days after surgery. Animals were given five to seven days for recovery, during which the mice were observed and handled daily. After this recovery period, each male and female received an infusion of V1aR antagonist or aCSF and was tested in the SI test as described above. One day later, males but not females were tested in the resident intruder test after receiving an injection of V1aR antagonist or aCSF (each male received same treatment as day before). An additional set of stressed females was implanted with guide cannulae aimed at the NAc shell as previously described (AP ¼ 0.51 mm, LM ¼ 1.1 mm, DV ¼ 6.85) . We decided to focus on NAc shell and no core because previous studies have implicated an important role of NAc shell on interaction behavior Trainor et al., 2011) . Seven days after recovery, each female received an infusion of V1aR antagonist or aCSF and was tested in the SI test. Males and control females were not included in this analysis due to very low V1aR binding levels.
V1aR antagonist infusion
In males and females, infusions into BNSTmv were made using bilateral internal cannulae Plastics One, C235I/SPC; 33ga; o.d. ¼ 0.21 mm; i.d. ¼ 0.11 mm, that projected 1 mm past the cannula guide (6.85 mm total length). In stressed females, infusions into NAc shell were made using bilateral internal cannulae Plastics One, C235I/SPC; 26ga; o.d. ¼ 0.46 mm; i.d. ¼ 0.24 mm. For injections both in BNSTmv and NAc shell, the V1aR antagonist [bMercapto-b,b-cyclopentamethylenepropionyl1, O-me-Tyr2, Arg8]-Vasopressin (Manning compound, Sigma catalog #:V2255) was dissolved in 2 ml aCSF, and frozen in 50 mL aliquots at a concentration of 0.5 mg/ml. Prior to daily injection, one aliquot was further dissolved in aCSF at a 1:20 dilution. Animals were randomly assigned to receive a 200 nl infusion per side containing either aCSF or 5 ng of V1aR antagonist. This dose was adjusted from dose previously shown to have behavioral effects when injected into BNST in rats (10 ng per side) (Gray et al., 2012; Veenema et al., 2010) . Using a California mouse brain atlas (brainmaps.org) we estimated that the sizes of the BNST and NAc are about 50% smaller in California mice compared to rats. Hamilton syringes were attached to an automatic micropump delivery apparatus (PHD 2000, Harvard Apparatus, Cambridge, MA) set to deliver 0.1 uL/min. Internal guides were kept in place for 1 min after injection. Both males and females were given one infusion, returned to the home cage, and then tested in SI after 30 min ( Figs. 1 and 2 ). Females in experiments 2 (injection in BNSTmv) and 4 (injection in NAc shell) were euthanized after testing to determine injection sites (for hits in BNSTmv, see Fig. 3 . Hits in NAc shell are not shown). One day after SI, males were tested in the resident-intruder test (described below) 30 min after receiving a second infusion of the same treatment they had received the day before. Males where then euthanized after testing to determine injection sites (Fig. 3) .
Resident-intruder test (RI)
One day after SI, males were tested in RI as previously described . Cage bedding had not been changed for three days, which has been shown to increase aggressive behavior (Bester-Meredith et al., 1999) . Thirty minutes after the infusion of the V1aR antagonist or aCSF, an unfamiliar same-sex intruder was introduced into the home cage of the experimental animal (resident). Tests lasted for 7 min after which the intruder was removed. Tests were video recorded and bouts of aggression, social investigation, and defensive behaviors (freezing, escape) were quantified as previously described Trainor et al., 2010) (Table 1) .
Histology
Brains were fixed overnight in 5% acrolein in PBS, after which they were immersed in 20% sucrose in PBS for a day, frozen and sectioned coronally at 40 mm. In order to confirm needle placement, sections were stained using NeuroTrace ® 435/455 Blue Fluorescent Nissl Stain (Life Technologies). Mice with injection sites outside of the BNSTmv for experiments 2 and 3 and NAc shell for experiment 4 were excluded from statistical analysis. Resident not active behavior but not freezing
Estrous cycle assessment
Conducting vaginal lavage before testing disrupts behavior in California mouse (Silva et al., 2010) , so estrous cycle was assessed post mortem. There was no systematic bias in the distribution of estrous stage across treatment groups.
Statistical analysis
All the statistical analyses were performed with R software. For receptor autoradiography data we used two-way ANOVA (sex and stress). We also performed regression analyses of time spent engaged in social interaction using sex, V1aR binding, and their interaction as parameters (package "ggplot"). Two-way ANOVA was used to analyze behaviors in the SI and RI tests (stress and treatment). For two-way ANOVA analyses that showed a significant interaction between stress and treatment, planned comparisons were used to detect differences between groups (package "lsmeans", Bonferroni, 0.95 confidence interval). Cohen's d is used to report effect size in this case. Finally, we also performed a 3-way ANOVA to assess possible effects of estrous cycle (stress, treatment and estrous cycle) in the SI test.
Results
Experiment 1:Effect of stress on V1aR binding in males and females
There was a stress*sex interaction on V1aR expression in NAc core (Fig. 4a, F 1,24 ¼ 6.39, p < 0.05) and shell (Fig. 4b, F 1,24 ¼ 4.33, p < 0.05). In males, there was no effect of defeat stress on V1aR expression in NAc core (p ¼ 0.9, Cohen's d (d) ¼ 0.15) or shell (p ¼ 0.83, d ¼ 0.05), while in females, defeat stress significantly increased expression of V1aR in NAc core (Fig. 4a, F 1,13 ¼ 8.42, p < 0.05, d ¼ 1.17) and shell (Fig. 4b, F 1,13 ¼ 6.42, p < 0.05, d ¼ 1.34) . In the BNSTmv, dorsal BNST, lateral septum (LS) dorsal, LS ventral, paraventricular nucleus (PVN), and medial preoptic area (mPOA), there were no main effects of sex or stress (Fig. 4ceh) . However, regression modeling of interaction time including the parameters of sex, V1aR binding, treatment, and the interaction between sex and V1aR binding revealed a significant difference between the slopes of V1aR binding in BNSTmv and interaction time in males and females (Fig. 5a , regression model F 4,22 ¼ 5.21, sex * V1aR, p ¼ 0.004). We also found a significant sex difference between slopes of V1aR binding in NAc core and interaction time (Fig. 5b , regression model F 4,22 ¼ 3.41, sex * V1aR p ¼ 0.043), but this was mainly driven by an outlier. Regression models did not indicate any significant interaction between slopes for males and females for any other of the areas analyzed (all p's > 0.1, Table 2 ).
Experiment 2: effects of V1aR antagonist in BNSTmv on female behavior
During the social interaction phase, both defeat (Fig. 6d,  F 1 ,28 ¼ 5.74, p ¼ 0.02) and V1aR antagonist (Fig. 6d, F 1,28 ¼ 5.08, p ¼ 0.03) reduced time spent in the interaction zone. Although the stress*antagonist interaction was not significant (Fig. 6d,  F 1 ,28 ¼ 0.84, p ¼ 0.36), planned comparisons revealed that V1aR antagonist reduced social interaction in control females (Fig. 6d , p ¼ 0.01, d ¼ 1.29) but not in stressed females (Fig. 6d, p 
. This is likely due to a floor effect, because stressed females treated with aCSF had significantly reduced social interaction compared to control females treated with aCSF (Fig. 6d , p ¼ 0.02, d ¼ 1.33). Interestingly, the effect size of V1aR antagonist in control females was similar to the effect size of social defeat in aCSF treated females. In females the effect of the V1aR antagonist in the BNSTmv appeared specific to social contexts, as there was no effect of V1aR antagonist in the acclimation phase on time in the interaction zone (Fig. 6c) . However, defeat stress reduced time spent in the interaction zone during the acclimation phase (F 1,29 ¼ 12.06, p ¼ 0.001, Fig 6c) . There were no differences in time spent in the center (Fig. 6a) or locomotor behavior (Fig. 6b) during the open field phase. When estrous phase was included in the ANOVA, there was no effect of cycle on time spent in the cage during acclimation or time spent in open field (Table 3 , all p's > 0.1).
Experiment 3: effects of V1aR antagonist in BNSTmv on male behavior
During open field testing, there was a significant stress*treatment interaction on time spent in center (F 1,31 ¼ 7.66, p ¼ 0.009, Fig. 6e ). V1aR antagonist significantly reduced time spent in the center only in naïve animals (p ¼ 0.02, d ¼ 1.14), but not in stressed animals (p ¼ 0.16, d ¼ 0.74). There were no differences in total distance traveled (Fig. 6f) . During the SI test, there were no main effects of stress or treatment on time spent in the interaction area, but there was a trend for a stress*treatment interaction (F 2,34 ¼ 3.64, p ¼ 0.06). Planned comparisons revealed that V1aR antagonist significantly reduced interaction time in naïve (p ¼ 0.03, d ¼ 1.11) but not stressed males (p ¼ 0.7, d ¼ 0.18) (Fig. 6h) . During acclimation phase, there was a main effect of V1aR to reduce time spent in proximity to the empty cage (Fig. 6g, F 1 In the RI test there was a significant stress*treatment interaction on latency to box (Fig. 7a, F 1 ,31 ¼ 7.36, p ¼ 0.01), with V1aR antagonist significantly increasing latency in stressed animals (p ¼ 0.04, d ¼ 0.94), and with no effect in naive animals (p ¼ 0.1, d ¼ 0.82). No significant differences were observed in other behaviors quantified during the RI.
Experiment 4: effects of V1aR antagonist in NAc shell on female behavior
The V1aR antagonist reduced time spent in the center during open field testing in stressed females (Fig. 8a, F 1,13 ¼ 4.90, p ¼ 0.04). There was no effect of V1aR on social interaction time, time spent in the cage zone during acclimation or distance traveled during open field (Fig. 8 b,c, and d) .
Discussion
Our results suggest that in both males and females, V1aR acting in BNSTmv facilitates social approach in naïve but not stressed animals. Interestingly, while V1aR inhibition in the BNSTmv had anxiogenic effects in both social and nonsocial contexts in males, the effects of V1aR inhibition in the BNSTmv in females were limited to social contexts. Infusions of the V1aR antagonist in the NAc shell, an area which is anatomically close to BNSTmv, had an anxiogenic effect in a non-social context in stressed females. Together, these data suggest that effects of V1aR on anxiety-like in males is less context-dependent in males and that in females different populations of V1aR modulate anxiety-like behaviors in social and non-social contexts.
Anxiogenic effects of social defeat stress and V1aR antagonist
We previously showed in the California mouse that three episodes of social defeat stress induce social withdrawal in females but not males. In addition stress increased the activity of OT neurons in the BNSTmv (Steinman et al., 2016 ). When we observed that females with more V1aR binding in the BNSTmv engaged in less social interaction, we hypothesized that increased OT release might reduce social interaction through V1aR (Song et al., 2014) . However, the results from our experiments using V1aR infusions do not support this hypothesis. V1aR antagonist in the BNSTmv had no effect in stressed females and actually reduced social interaction behavior in both males and females naïve to defeat. Previous work has demonstrated that global V1aR inhibition in male rodents also reduces social interaction. For example, systemic injection of OT or AVP in adult male rats increased social interaction and these effects were blocked by systemic injections of the V1aR antagonist SR49059 (Ramos et al., 2013) . Similarly, male V1aR knockout mice exhibited reduced social interaction behavior compared to wildtype littermates (Egashira et al., 2007) . Our results suggest that these effects of V1aR observed in male rodents generalize to females, and may be mediated in part by V1aR in the BNSTmv. Although we did not specifically include an anatomical control in this study, we observed different effects of V1aR antagonist infused in the NAc (see below). Our results highlight the sex-and experience-dependent effects of central V1aR and leave open the question of whether V1aR expressing regions adjacent to BNSTmv may modulate social behaviors.
Autoradiography data also showed that stress increased V1aR binding in the NAc shell and NAc core in females but not males. Previous autoradiography studies in rodents have reported low levels of V1aR binding in the NAc (Johnson et al., 1993) , so this stress-induced effect is a novel finding. The NAc shell has been previously implicated in sex specific effects of social defeat in California mouse Trainor et al., 2011) , so we next hypothesized that stress-induced increases in OT neural activity in females might reduce social interaction behavior by activating V1aR in the NAc shell. However, V1aR antagonist infusions into the NAc shell in stressed females had no effect on social interaction behavior. It's possible that V1aR in NAc core may work together with V1aR in NAc shell to inhibit social interaction behavior and that more global inhibition of V1aR in NAc might be necessary to see an effect on this behavior. Still, our results do not support the hypothesis that increased V1aR activity contributes to stressinduced decreases in social interaction behavior in females.
Effects of V1aR inhibition on behavior: interaction with social defeat stress
While V1aR inhibition within the BNSTmv reduced social interaction behavior males and females naïve to defeat, there were no effects in stressed mice. Intriguingly, the effects of V1aR antagonist on social interaction in control mice were often similar to effects of social defeat in mice treated with aCSF. It's possible that effects of defeat stress on male behavior could be mediated through decreased availability of AVP. Defeat stress reduces AVP immunoreactivity in both the PVN and BNST while lowering also Avp mRNA expression in the PVN of males . Similar effects have been observed in male Mus musculus (Reber et al., 2007) . However in our previous studies, social defeat alone was insufficient to reduce social interaction in males , 2015; Trainor et al., 2011; Trainor et al., 2013) . Only when stressed male California mice receive an acute stressor such as an intranasal infusion (Steinman et al., 2016) or intracranial infusion (this paper) is reduced social interaction observed. Handling or immobilization increases the activity of locus coeruleus (LC) neurons (Kawahara et al., 2000) and norepinephrine release (Smagin et al., 1997) , which in turn can reduce social interaction in male rats (Cecchi et al., 2002; Varlinskaya and Spear, 2012) . It's possible that social defeat exaggerates these responses. For example social defeat increased corticotropin releasing hormone (CRH) in the LC (Reyes et al., 2015) and CRH is known to increase neural discharge rates of LC neurons (Curtis et al., 1997; Jedema and Grace, 2004) . If stressed male California mice had increased noradrenergic responses to handling, this might account for decreased social interaction following infusions.
Context-dependent effects of V1aR inhibition on behavior
There were also sex differences in how V1aR modulated behavior in social and nonsocial contexts. For males V1aR inhibition in the BNSTmv had anxiogenic effects in social and nonsocial contexts, but in females V1aR inhibition only affected behavior in social contexts. Thus it appears that in males the effects of V1aR in the BNSTmv on anxiety-like behavior are no dependent on social context. For females V1aR receptors in BNSTmv affect behavior in social contexts but not non-social contexts. Interestingly we found an anxiolytic role for V1aR in NAc shell in females. To our knowledge anxiolytic effects of V1aR in the NAc shell have not been reported. The 3-fold increase in V1aR binding in stressed females but not males is particularly interesting in the context of the open field test. Defeat reduced time in the center of the open field in males but not females. These results suggest that, in socially stressed females, V1aR could be exerting a 'compensatory' effect, reducing the effects of stress on exploration in an unfamiliar, non-social environment.
Intriguingly, while V1aR inhibition had no effect on behavior in stressed males in an unfamiliar environment, it did affect behavior in stressed males tested in the RI test. When focal males were tested as residents in a familiar home cage, stress significantly decreased latency to box in males, which is considered a defensive behavior (Linfoot et al., 2009; Litvin et al., 2007) . These effects were partially reversed by the injection of V1aR antagonist into BNSTmv. Previous work in males has shown that the effects of V1aR are stronger in familiar environments compared to novel environments (Bester-Meredith and Marler, 2001) . For the RI test, it's important to consider that V1aR antagonist treated mice were receiving a second injection. Thus it's possible that prolonged inhibition of V1aR might have a different behavioral effect than acute inhibition.
Conclusions
Our results suggest that a specific population of V1aR in BNSTmv exerts anxiolytic effects in both social and nonsocial contexts for males but that for females the anxiolytic effects of these receptors is limited to social contexts. While prosocial effects of V1aR have been previously reported (Pitkow et al., 2001; Ramos et al., 2013) , most studies have found anxiogenic effects of systemic V1aR inactivation in non-social contexts (Bielsky et al., 2004; Mak et al., 2012) . Interestingly, overexpression of V1aR in the ventral pallidum of male prairie voles had anxiogenic effects in the elevated plus maze (Pitkow et al., 2001) , suggesting that effects of V1aR on anxiety-like behavior are site specific. This is similar to the behavioral effects of brain derived neurotrophic factor which has antidepressant effects in hippocampus (Autry et al., 2011) , but pro-depressive effects in NAc or BNST (Berton et al., 2006; Greenberg et al., 2014) . Thus it appears that specific populations of V1aR have different effects on anxiety depending on neuroanatomical location, context, and sex. This means that any investigation of potential therapeutic use of V1aR targeting drugs needs to take these factors in to account. Continued study of the effects of V1aR on neural circuits of anxiety in rodents and humans should provide important insights in the potential of V1aR as a novel therapeutic target. 
